Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial

Juergen K. Rockstroh, Frank Plonski, Meena Bansal, Gerd Fätkenheuer, Catherine B. Small, David Asmuth, Gilles Pialoux, Rebecca Zhang-Roper, Ronnie Wang, Juan A. Pineda, Jayvant Heera

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences